CellCarta Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
1,000
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
10
CellCarta General Information
Description
Operator of a contract research organization laboratory intended for the pharmaceutical and biotechnology industries. The company specializes in proteomics and immune monitoring that offer proprietary multiparametric flow cytometry services for functional analyses of innate and adaptive immune responses and proteomics testing, enabling clients with a comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for the discovery and validation of protein biomarkers.
Contact Information
Website
www.cellcarta.comCorporate Office
- 201 President Kennedy Avenue
- Suite 3900
- Montreal, Quebec H2X 3Y7
- Canada
Corporate Office
- 201 President Kennedy Avenue
- Suite 3900
- Montreal, Quebec H2X 3Y7
- Canada
CellCarta Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CellCarta Comparisons
Industry
Financing
Details
CellCarta Competitors (3)
One of CellCarta’s 3 competitors is Everest Clinical Research, a Private Equity-Backed company based in Markham, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Everest Clinical Research | Private Equity-Backed | Markham, Canada | ||||
| Meso Scale Diagnostics | Corporation | Rockville, MD | ||||
| PeproTech | Corporate Backed or Acquired | Cranbury, NJ |
CellCarta Patents
CellCarta Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10935549-B2 | Biomarkers of latent tuberculosis infection | Active | 14-Jul-2016 | ||
| US-20190277846-A1 | Biomarkers of latent tuberculosis infection | Active | 14-Jul-2016 | ||
| WO-2018013883-A1 | Biomarkers of latent tuberculosis infection | Inactive | 14-Jul-2016 | ||
| WO-2018013883-A8 | Biomarkers of latent tuberculosis infection | Inactive | 14-Jul-2016 | ||
| AU-2014233935-A1 | Brucellosis, q-fever, and lyme disease biomarkers and uses thereof | Inactive | 21-Mar-2013 | G01N33/6848 |
CellCarta Signals
CellCarta Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CellCarta Investments (10)
CellCarta’s most recent deal was a Buyout/LBO with Precision Assays (Commercial Rights To Immuno-MRM Assays). The deal was made on 17-May-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Precision Assays (Commercial Rights To Immuno-MRM Assays) | 17-May-2022 | Buyout/LBO | Buildings and Property | ||
| Biogazelle | 14-Dec-2021 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| Reveal Biosciences | 11-May-2021 | Buyout/LBO | Discovery Tools (Healthcare) | ||
| Mosaic Laboratories | 12-Jan-2021 | Buyout/LBO | Biotechnology | ||
| Clinical Logistics | 07-Jan-2021 | Buyout/LBO | Medical Supplies |
CellCarta Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Mosaic Laboratories | Lake Forest, CA | 2005 | |
| Histogenex | Antwerp, Belgium | 2001 |
CellCarta FAQs
-
When was CellCarta founded?
CellCarta was founded in 2000.
-
Where is CellCarta headquartered?
CellCarta is headquartered in Montreal, Canada.
-
What is the size of CellCarta?
CellCarta has 1,000 total employees.
-
What industry is CellCarta in?
CellCarta’s primary industry is BPO/Outsource Services.
-
Is CellCarta a private or public company?
CellCarta is a Private company.
-
What is the current valuation of CellCarta?
The current valuation of CellCarta is .
-
What is CellCarta’s current revenue?
The current revenue for CellCarta is .
-
Who are CellCarta’s investors?
Arsenal Capital Partners has invested in CellCarta.
-
Who are CellCarta’s competitors?
Everest Clinical Research, Meso Scale Diagnostics, and PeproTech are competitors of CellCarta.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process